Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol Myers Squibb describes FPR2 and FPR1 agonists

March 8, 2022

SiteOne Therapeutics patents Nav1.7 inhibitors for pain

March 8, 2022

Kidney organoids as models of tubular injury reveal a key role of HDR genes in kidney repair

March 8, 2022

Novartis enters license option agreement with Voyager for AAV capsids for gene therapy programs

March 8, 2022

Study finds variants that increase risk of severe COVID-19

March 8, 2022

METTL3 inhibition with STM-2457 leads to antitumor effects in OSCC

March 8, 2022

LABP-73 demonstrates efficacy in preclinical models of chronic asthma

March 8, 2022

BMAL1 disruption has an impact on metabolic and liver disease

March 8, 2022

Nanoengineered Bifidobacterium bifidum suppresses tumors in vivo

March 8, 2022

VYN-201 reduces key inflammatory biomarkers involved in vitiligo pathogenesis in preclinical model

March 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.